CURE’s anal cancer page is an extensive resource of cancer information featuring the latest anal cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on anal cancer.
September 14th 2024, 11:00pm
Adding Zynyz to carboplatin and paclitaxel prolonged survival without progression in chemotherapy-naive recurrent or metastatic squamous cell carcinoma of the anal canal.
August 13th 2024, 1:00pm
Helping others through their cancer experience helped with my own feelings of survivor's guilt.
September 1st 2023, 9:00pm
At first, I thought I had hemorrhoids, but ended up eventually being diagnosed with anal cancer.
April 18th 2023, 9:00pm
HPV vaccination rates and public knowledge about the connection between the virus and certain cancer types are below what they should be, research found.
January 4th 2023, 10:00pm
A novel three-drug combination bested standard-of-care regimens for patients with human papillomavirus-related cancers, according to phase 2 study results.
September 21st 2022, 9:00pm
Cancer made me more empathetic, as well as an advocate for the HPV vaccine.
September 6th 2022, 1:00pm
After I was diagnosed with anal cancer, doctors wanted me to get an colostomy bag, but I refused. Later on, I had to voice my concern about a drug that could improve my chances for survival.
January 22nd 2021, 7:00pm
The priority review will focus on retifanlimab for the treatment of certain adult patients with locally advanced or metastatic squamous cell carcinoma of the anal canal who did not tolerate platinum-based chemotherapy. Currently, according to Incyte, there are no approved treatments for this patient population.
August 24th 2020, 9:00pm
To halt the rise of anal cancer, everyone eligible needs to be vaccinated against HPV, which causes most cases of the disease.
February 25th 2020, 12:40am
Sexual and gender minorities are not receiving the same standard of clinical care as other patients with cancer.
Chemo-Radiotherapy Combo May Improve Survival in Advanced Cervical Cancer
FDA Approval Withdrawal of Trodelvy Leaves Fewer Bladder Cancer Options
Sometimes, Cancer Just Gets in My Way
Cyramza-Tagrisso Combo Prolongs PFS in Some Patients With NSCLC Subset